17-year follow-up of a randomized prospective controlled trial of adjuvant intravesical doxorubicin in the treatment of superficial bladder cancer

International Braz J Urol

Volumn 31, Issue 3, 2005, Pages 204-213

  Cheng, Chi Wai ^a,b   Chan, P S ^a,b   Chan, L W ^a,b   Chan, C K ^a,b   Ng, C F ^a,b   Lai, M M ^a,b  

^a CHINESE UNIVERSITY OF HONG KONG   (Hong Kong)

^b CHINESE UNIVERSITY OF HONG KONG   (Hong Kong)

Author keywords

Bladder neoplasms; Doxorubicin; Intravesical instillations; Transitional cell

Indexed keywords

DOXORUBICIN;

ADULT; AGED; ARTICLE; BLADDER CANCER; BONE METASTASIS; CANCER ADJUVANT THERAPY; CANCER GRADING; CANCER GROWTH; CANCER RECURRENCE; CANCER STAGING; CANCER SURVIVAL; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DRUG EFFICACY; FEMALE; FOLLOW UP; HUMAN; KAPLAN MEIER METHOD; LIVER METASTASIS; LONG TERM CARE; LYMPH NODE METASTASIS; MAJOR CLINICAL STUDY; MALE; MULTIVARIATE ANALYSIS; PLEURA EFFUSION; PREDICTION; PROGNOSIS; RANDOMIZED CONTROLLED TRIAL; TRANSITIONAL CELL CARCINOMA; TUMOR VOLUME;

EID: 22844433408     PISSN: 16775538     EISSN: None     Source Type: Journal    
DOI: 10.1590/S1677-55382005000300003     Document Type: Article

References (12)

1. Kurth K, Tunn U, Ay R, Schroder FH, Pavone-Macaluso M, Debruyne F, et al.: Adjuvant chemotherapy for superficial transitional cell bladder carcinoma: long-term results of a European Organization for Research and Treatment of Cancer randomized trial comparing doxorubicin, ethoglucid and transurethral resection alone. J Urol. 1997; 158: 378-84.
2. Akaza H, Koiso K, Kotake T, Matsumura Y, Isaka S, Machida T, et al.: Long-term results of intravesical chemoprophylaxis of superficial bladder cancer: experience of the Japanese Urological Cancer Research Group for Adriamycin. Cancer Chemother Pharmacol. 1992; 30 (Suppl): S15-20.
3. Shinohara N, Nonomura K, Tanaka M, Nagamori S, Takakura F, Seki T, et al.: Prophylactic chemotherapy with anthracyclines (adriamycin, epirubicin, and pirarubicin) for primary superficial bladder cancer. The Hokkaido University Bladder Cancer Collaborative Group. Cancer Chemother Pharmacol. 1994; 35 (Suppl): S41-5.
4. Burk K, Schultze-Seemann W, Rodeck G: Tur vs TUR plus adriamycin in patients with superficial bladder cancer - a five-year follow-up. Prog Clin Biol Res. 1989; 303: 417-22.
5. Huland H, Kloppel G, Feddersen I, Otto U, Brachmann W, Hubmann H, et al.: Comparison of different schedules of cytostatic intravesical instillations in patients with superficial bladder carcinoma: final evaluation of a prospective multicenter study with 419 patients. J Urol. 1990; 144: 68-71; discussion 71-2.
6. Bouffioux C, Kurth KH, Bono A, Oosterlinck W, Kruger CB, De Pauw M, et al.: Intravesical adjuvant chemotherapy for superficial transitional cell bladder carcinoma: results of 2 European Organization for Research and Treatment of Cancer randomized trials with mitomycin C and doxorubicin comparing early versus delayed instillations and short-term versus long-term treatment. European Organization for Research and Treatment of Cancer Genitourinary Group. J Urol. 1995; 153: 934-41.
7. Lamm DL, Crissmann J, Blumenstein B, Crawford ED, Montie J, Scardino P, et al.: Adriamycin versus BCG in superficial bladder cancer: a Southwest Oncology Group Study. Prog Clin Biol Res. 1989; 310: 263-70.
8. Martinez-Pineiro JA, Jimenez Leon J, Martinez-Pineiro L Jr, Fiter L, Mosteiro JA, Navarro J, et al.: Bacillus Calmette-Guerin versus doxorubicin versus thiotepa: a randomized prospective study in 202 patients with superficial bladder cancer. J Urol. 1990; 143: 502-6.
9. Lamm DL, Blumenstein BA, Crawford ED, Montie JE, Scardino P, Grossman HB, et al.: A randomized trial of intravesical doxorubicin and immunotherapy with bacille Calmette-Guerin for transitional-cell carcinoma of the bladder. N Engl J Med. 1991; 325: 1205-9.
10. Gustafson H, Tribukait B, Esposti PL: DNA pattern, histological grade and multiplicity related to recurrence rate in superficial bladder tumours. Scand J Urol Nephrol. 1982; 16: 135-9.
11. Gustafson H, Tribukait B, Esposti PL: DNA profile and tumour progression in patients with superficial bladder tumours. Urol Res. 1982; 10: 13-8.
12. Isaka S, Okano T, Shimazaki J, Igarashi T, Murakami S, Higa T, et al.: Prophylaxis of superficial bladder cancer with instillation of adriamycin or mitomycin C. Cancer Chemother Pharmacol. 1987; 20(Suppl): S77-80.